This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...